315
Views
11
CrossRef citations to date
0
Altmetric
Review Articles

Toward a better understanding of metabolic and pharmacokinetic characteristics of low-solubility, low-permeability natural medicines

, , , , , , , , & ORCID Icon show all
Pages 19-43 | Received 21 Sep 2019, Accepted 11 Dec 2019, Published online: 26 Jan 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ran Chen, Tingting Wang, Jie Song, Daojun Pu, Dan He, Jianjun Li, Jie Yang, Kailing Li, Cailing Zhong & Jingqing Zhang. (2021) Antiviral Drug Delivery System for Enhanced Bioactivity, Better Metabolism and Pharmacokinetic Characteristics. International Journal of Nanomedicine 16, pages 4959-4984.
Read now

Articles from other publishers (10)

Ghassan Mudher Hashim, Ghaidaa S. Hameed & Dalya Basil Hanna. (2023) The possible techniques that used to improve the bioavailablity, pharmacological activity, solubility and permeability of anti-viral drugs: Insight for COVID-19 antiviral drugs. Al Mustansiriyah Journal of Pharmaceutical Sciences 23:3, pages 231-249.
Crossref
M. A Agafonov & I. V Terekhova. (2023) Features of complex formation of native and polymeric β-cyclodextrins with sulfasalazine. Журнал общей химии 93:5, pages 785-793.
Crossref
M. A. Agafonov & I. V Terekhova. (2023) Features of Complex Formation of Native and Polymeric β-Cyclodextrins with Sulfasalazine. Russian Journal of General Chemistry 93:5, pages 1130-1137.
Crossref
Wim Ceelen, Louis Sandra, Leen Van de Sande, Martin Graversen, Michael Bau Mortensen, An Vermeulen, Elke Gasthuys, Dries Reynders, Sarah Cosyns, Anne Hoorens & Wouter Willaert. (2022) Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases. eBioMedicine 82, pages 104151.
Crossref
Tarapong Srisongkram, Katayun Bahrami, Juulia Järvinen, Juri Timonen, Jarkko Rautio & Natthida Weerapreeyakul. (2022) Development of Sesamol Carbamate-L-Phenylalanine Prodrug Targeting L-Type Amino Acid Transporter1 (LAT1) as a Potential Antiproliferative Agent against Melanoma. International Journal of Molecular Sciences 23:15, pages 8446.
Crossref
Jiaxi Xie, Cailing Zhong, Tingting Wang, Dan He, Luyang Lu, Jie Yang, Ziyi Yuan & Jingqing Zhang. (2022) Better Bioactivity, Cerebral Metabolism and Pharmacokinetics of Natural Medicine and Its Advanced Version. Frontiers in Pharmacology 13.
Crossref
Meshal Alshamrani, Muhammad Khalid Khan, Barkat Ali Khan, Ahmad Salawi & Yosif Almoshari. (2022) Technologies for Solubility, Dissolution and Permeation Enhancement of Natural Compounds. Pharmaceuticals 15:6, pages 653.
Crossref
Tarapong Srisongkram & Natthida Weerapreeyakul. (2022) Route of intracellular uptake and cytotoxicity of sesamol, sesamin, and sesamolin in human melanoma SK-MEL-2 cells. Biomedicine & Pharmacotherapy 146, pages 112528.
Crossref
Gustavo Marinho Miranda, Vitória Ohana Ramos e Santos, Jonatas Reis Bessa, Yanna C. F. Teles, Setondji Cocou Modeste Alexandre Yahouédéhou, Marilda Souza Goncalves & Jaime Ribeiro-Filho. (2021) Inclusion Complexes of Non-Steroidal Anti-Inflammatory Drugs with Cyclodextrins: A Systematic Review. Biomolecules 11:3, pages 361.
Crossref
Kun Zang, Jingtong Xia, Chengxin Wu, Shuping Yang, Wei Wang, Zhi-Cong Zeng, Lei Zhou & Qiaosheng Pu. (2021) After enjoying curry: urine metabolism analysis of curcuminoids by microemulsion electrokinetic chromatography with laser-induced native fluorescence detection. Journal of Chromatography A 1635, pages 461729.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.